On December 17, 2025, InMed Pharmaceuticals Inc. held its Annual General Meeting where shareholders approved the election of five directors and appointed CBIZ CPAs P.C. as the auditor. Additionally, shareholders approved potential issuance of 20% or more of the company's common shares under a specified agreement.